GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (ASX:SIG) » Definitions » EV-to-EBITDA

Sigma Healthcare (ASX:SIG) EV-to-EBITDA : 33.72 (As of May. 18, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sigma Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sigma Healthcare's enterprise value is A$1,795 Mil. Sigma Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was A$53 Mil. Therefore, Sigma Healthcare's EV-to-EBITDA for today is 33.72.

The historical rank and industry rank for Sigma Healthcare's EV-to-EBITDA or its related term are showing as below:

ASX:SIG' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.34   Med: 11.33   Max: 35.25
Current: 33.71

During the past 13 years, the highest EV-to-EBITDA of Sigma Healthcare was 35.25. The lowest was 6.34. And the median was 11.33.

ASX:SIG's EV-to-EBITDA is ranked worse than
91.25% of 80 companies
in the Medical Distribution industry
Industry Median: 10.07 vs ASX:SIG: 33.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Sigma Healthcare's stock price is A$1.235. Sigma Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was A$0.005. Therefore, Sigma Healthcare's PE Ratio for today is 247.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Sigma Healthcare EV-to-EBITDA Historical Data

The historical data trend for Sigma Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare EV-to-EBITDA Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.37 9.51 25.49 17.62 27.62

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.49 - 17.62 - 27.62

Competitive Comparison of Sigma Healthcare's EV-to-EBITDA

For the Medical Distribution subindustry, Sigma Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's EV-to-EBITDA falls into.



Sigma Healthcare EV-to-EBITDA Calculation

Sigma Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1795.490/53.25
=33.72

Sigma Healthcare's current Enterprise Value is A$1,795 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sigma Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was A$53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare  (ASX:SIG) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sigma Healthcare's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.235/0.005
=247.00

Sigma Healthcare's share price for today is A$1.235.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sigma Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was A$0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Sigma Healthcare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (ASX:SIG) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.